Interleukin-12 is a recently discovered lymphokine displaying an array of in vitro activities suggesting a major role in protective immunity against infectious agents like viruses. This study provides evidence that IL-12 may also be implicated in the selection of the immunoglobulin isotypes. We show that picomolar concentrations of rIL-12 markedly inhibit the synthesis of IgE by IL4-stimulated PBMC. The suppression of IgE is observed at the protein and at the mRNA levels, it is isotype specific, and it is abolished by neutralizing anti-IL-12 mAbs. IL-12 may suppress IgE synthesis by: (a) inducing the production of IFN-y, a known inhibitor of IgE synthesis and (b) by a novel mechanism which is IFN-y independent. The best evidence for this is from studies on IgE synthesis by IL-4-plus hydrocortisone-stimulated umbilical cord blood lymphocytes, which do not produce detectable amounts of IFN-'y. In such cultures, rIL-12 inhibits IgE synthesis even in the presence of a large excess of neutralizing anti-IFN-y mAb. (J. Clin. Invest. 1992. 90:262-266.)
Introduction
In vivo and in vitro observations have demonstrated that the synthesis of IgE is dependent upon the balance between the production of IL-4 and IFN-Iy at the sites of T/B cell interactions (1) (2) (3) . IL-4 may promote IgE synthesis not only via a direct effect on B cells, resulting in switching to IgE (4) (5) , but perhaps also by regulating the production ofother molecules or cytokines involved in IgE regulation. For example, IL-4 markedly inhibits IFN-y production by human lymphocytes stimulated by mitogen or allogeneic cells (6) (7) . In addition, IL-4 may also be involved in directing the differentiation of naive precursor T cells into TH2 type ofeffector cells, producing IL-4 but not IFN-'y (8) . Similarly, IFN--y suppresses the in vivo synthesis of IgE, not only by antagonizing the effect of IL-4 on the switching to IgE, but perhaps also by inhibiting the proliferation of IL-4-producing TH2 lymphocytes (9, 10) , or by directing the differentiation of naive precursor T cells into T cells IL-4 and IFN-y may also have an important role in the regulation ofIgE synthesis. Interferon-a, a cytokine mainly produced by accessory cells, is a potent inhibitor of the in vitro and in vivo synthesis of mouse and human IgE (1, 3) . IFN-a also counteracts the effect of IL-4 on the switching to IgE, and most interestingly, as IFN-y does, it inhibits the in vivo production of and enhances that of . Interleukin-12 is a novel cytokine which, like IFN-y and IFN-a, may be involved in protective immunity against infectious agents such as viruses (13) (14) (15) (16) (17) . Previously Cell preparations and culture conditions. Cells were prepared and cultured as described (19, 21) . Briefly, PBMC were isolated from heparinized venous blood of healthy individuals by centrifugation over Ficoll-Metrizoate. Umbilical cord blood was collected in heparin-containing tubes and was sedimented 45 min at 370C with dextran (10% vol/vol; mol wt 200, J. T. Baker Chemical Co., Phillipsburg, NJ); the leukocyte-rich plasma was then layered on Ficoll-Metrizoate. Cells were cultured in HB101 culture medium (Hana Biologics, Alemeda, CA) supplemented with 5% FCS (Flow Laboratories, Inc., McLean, VA), penicillin (100 U/ml), streptomycin (100 Mg/ml), L-glutamine (2 mM) (Gibco Laboratories), sodium pyruvate (10 mM), and Hepes (10 mM). Cells (2 X I05 in 0.2 ml) were cultured in four replicates or more in round-bottomed 96-well tissue culture plates (Linbro, Flow Laboratories, Hamden, CT) for 12 d in a humidified atmosphere of 5% CO2 and 95% air. For the induction of IgE synthesis, cultures were supplemented with IL-4 at the final concentration of 10 ng/ml. This concentration was found to be optimal for the induction of IgE synthesis and the suppression of IFN-,y production in mixed lymphocyte cultures.
RIAs. Immunoglobulins were measured in cell-free culture supernatants by means of solid phase RIAs exactly as described (19, 21) . IFN-y was measured by a commercially available RIA (Centocor Co., Malvern, PA) with a sensitivity of 1 IU/ml. The net synthesis ofIgs and of IFN-,y was determined by subtracting the values measured in the culture supernatants of cycloheximide-treated cells (50 ig/ml) from those of untreated cells. In preliminary experiments where the levels of IFN-,y in the supernatants of IL-12-stimulated cultures were determined at d 2, 4, 6, and 8, we found, in agreement with a previous report ( 17) , that a plateau was obtained between d 4 and 6. IFN-,y was therefore routinely measured on d 6. To this end, 50 ,l of culture supernatants were collected and replaced by the same volume of fresh culture medium. All the culture supernatants were stored at -20°C until the assay.
Northern blot analysis. Northern blot analysis was carried out exactly as described (6) . Briefly, total RNA was extracted from cultured PBMC by the guanidinium-thiocyanate method with CsCl gradient modification and quantified by measurement of absorbance at 260 nm. The samples (20 ,g per lane) were subjected to electrophoresis in formaldehyde-containing 1% agarose gel, and transferred to nylon membrane (Biotrans; ICN, Irvine, CA). The membrane was baked 2 h at 80°C under vacuum, prehybridized in 50% formamide/5 X Denhardt's/5 x standard saline citrate/ 10 mM EDTA/50 mM sodium phosphate pH 6.8/0.1% SDS/250,g/ml salmon sperm DNA, and incubated overnight at 420C with 32P-labeled cDNA probe in the same buffer. The probes used for the detection of the germ-line and the mature form of Cc mRNA were kindly provided by Dr. R. Geha and described by Jaraba et al. (22) . A 0.74-kb SmaI fragment overlapping the germline exon was used to detect germ-line Ct transcript, and the 0.88-kb Hinfl fragment encompassing most of the Cd1 exon and the totality of the CE2 exon was used to detect both the productive and the germ-line Ct mRNAs.
Results
Given that IL-12 and IL-4 are known to have opposite effects on IFN-y production by human lymphocytes, we first examined the effect of IL-12 on IgE and IFN-y production by IL-4-stimulated PBMC. As seen in Table I , rIL-12 (60 pM) significantly suppresses the production of IgE and increases the synthesis of IFN-y by PBMC cultured in the presence of a saturating concentration of IL4 (10 ng/ml). IL-4 significantly . Isotype-matched control antibodies (a mixture of rat IgG 1 and IgG2b, each at 10 ug/ml) had no effect (not shown). Fig. 2 , rIL-12 strongly suppresses the expression of the mature but not ofthe germ-line CE transcript. These observations demonstrate that IL-12 suppresses the synthesis of IgE, and they further suggest that IL-12 inhibits the switching to IgE. We next examined the possibility to dissociate the IgE suppressive activity of IL-12 from its IFN--y inducing activity.
To this end we have tested the effect ofIL-12 on the synthesis of IgE by umbilical cord blood mononuclear cells (CBMC) costimulated with IL-4 and hydrocortisone (HC). These cells were selected because of their impaired capacity to produce IFN-"y (23) and because exogenous IFN-y was found to increase rather than to inhibit their synthesis of IgE following stimulation with IL-4 (6) . HC was added to IL-4-stimulated CBMC for two reasons: (a) HC inhibits the production ofIFN-y, even that induced by IL-12 (our preliminary observations); and (b) HC strongly increases the IL-4-stimulated synthesis of IgE, even in the absence of IFN-y production (24) . As seen (Table II) , rIL-12 markedly inhibits IgE synthesis by neonatal cells cultured in the presence ofIL-4 plus hydrocortisone and producing little or no detectable IFN-y. Moreover, the suppression is unchanged in the presence of a large excess of neutralizing anti-IFN--y mAb. Thus, it appears that IL-12 can inhibit IgE synthesis by a mechanism which is independent of IFN-y. This view is consistent with the observation that IL-12 inhibits IgE synthesis by PBMC costimulated with IL-4 and anti-CD40 mAb, a model where IFN-'y was reported to be inactive (25) . In three such experiments where PBMC were cultured with IL-4 and anti-CD40 mAb 89 (0.5 ,ug/ml), the production of IgE dropped from 70±28 ng/ml (mean± 1 SD) to 20±8 ng/ml in the presence of rIL-12 (60 pM), as compared to 79±35 ng/ml in the presence of IFN-'y (100 IU/ml). However, IL-12 failed to inhibit the IgE response of highly purified B cells costimulated with IL-4 and anti-CD40 mAb, (106±40 ng/ml of IgE in the absence of IL-12 as opposed to 123±73 ng/ml in the presence of 60 pM IL-12; mean± 1 SD of four experiments), indicating that the suppressive effect observed in cultures of unfractionated PBMC is indirect and requires the presence of either T cells, monocytes, or NK cells. Discussion This study indicates that picomolar concentrations of rIL-12 markedly inhibit the synthesis of IgE by IL-4-stimulated PBMC. The suppression of IgE is observed at the protein and the mRNA levels, and it is completely overridden by neutralizing antibodies to IL-12. Given that the production of IgE by IL-4-stimulated lymphocytes involves the switching ofprecursor B cells to IgE rather than the selective expansion and differentiation of IgE committed B cells (4, 26) , the results suggest that IL-12 inhibits the switching to IgE. Consistent with an isotype-specific activity of IL-12, we failed to detect any influence of this lymphokine on the production of the other classes of Ig by IL-4-or by PWM-stimulated PBMC. However, the data do not exclude a possible effect ofIL-12 on the production of IgG4, the only human isotype other than IgE that is induced by IL-4 (4). Indeed, IgG4 is produced in much smaller quanti- (28) .
In preliminary experiments using neutralizing antibodies to IFN-,y we failed to consistently overcome the IL-12 mediated suppression of IgE synthesis by adult PBMC. Although these negative results may be easily explained by: (a) the relatively high levels of IFN--y in IL-12 containing cultures; and (b) the difficulty to block the biological activity of endogenously produced IFN-y, they prompted us to examine whether IL-12 may also suppress IgE by another mechanism which is IFN-,y independent. The existence of such a mechanism is demonstrated by the ability of IL-12 to markedly inhibit IgE synthesis by IL-4 and hydrocortisone-costimulated neonatal lymphocytes which do not produce detectable amounts of IFN-y. The possibility that such undetectable levels of IFN-y (< 1 IU) might nevertheless account for the suppression of IgE is most unlikely given that a very large excess ofneutralizing anti-IFNy antibody failed to increase the IgE response. Two other observations are consistent with the notion that IL-12 mediated suppression of IgE does not only involve the induction ofIFNy. First, comparing our results on the accumulation of germline and mature IgE mRNAs with those of a recent study (5) reveals that whereas both IL-12 and IFN-,y markedly suppress the accumulation of productive CE mRNA in IL-4-stimulated PBMC (> 90% suppression), IFN--y, but not IL-12, also suppresses the expression of germ-line transcript (50-70% inhibition). Second, we observed that IL-12 suppresses IgE synthesis by PBMC costimulated with IL-4 and anti-CD40 mAb, a model where IFN-,y is known to be inactive (25) . In this case, however, the effect of IL-12 is indirect and requires the presence of either T cells, monocytes, or NK cells, as evidenced by the failure of IL-12 to block IgE synthesis by highly purified B cells costimulated with IL-4 and anti-CD40 mAb. Although the mechanism whereby IL-12 inhibits IgE synthesis in the absence of IFN-y production is still under investigation, the present results suggest that, like the interferons, IL-12 may not only play an important role in protective immunity, but also in the regulation of isotype selection.
